DiaSorin launches FDA-Cleared LIAISON® Calprotectin test in the US market

31/01/2019

DiaSorin is pleased to announce the US launch of the FDA-Cleared LIAISON® Calprotectin test for the quantitative measurement of Calprotectin in stool samples. Following the recently announced strategic collaboration with Meridian Bioscience to sell Helicobacter pylori stool antigen test, DiaSorin continues to expand its Gastro-Intestinal portfolio in the United States